Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intestinal Microbiome Post-Azithromycin/Albendazole
NCT03032042Phase 4Withdrawn
- Sponsor
- University of California, San Francisco
- Start
- Jan 2017
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of albendazole, azithromycin in soil-transmitted helminth infection (STH), sponsored by University of California, San Francisco. Planned start Jan 2017; status: withdrawn.
02
Drugs
albendazoleazithromycin
03
Conditions
soil-transmitted helminth infection (STH)
Beyond the preview
Go deeper on NCT03032042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03032042.